Insight and subjective measures of quality of life in chronic schizophrenia

Cynthia O. Siu, Philip D Harvey, Ofer Agid, Mary Waye, Carla Brambilla, Wing Kit Choi, Gary Remington

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Lack of insight is a well-established phenomenon in schizophrenia, and has been associated with reduced rater-assessed functional performance but increased self-reported well-being in previous studies. The objective of this study was to examine factors that might influence insight (as assessed by the Insight and Treatment Attitudes Questionnaire [ITAQ] or PANSS item G12) and subjective quality-of-life (as assessed by Lehman QoL Interview [LQOLI]), using the large National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) dataset. Uncooperativeness was assessed by PANSS item G8 ("Uncooperativeness"). In the analysis, we found significant moderating effects for insight on the relationships of subjective life satisfaction assessment to symptom severity (as assessed by CGI-S score), objective everyday functioning (as assessed by rater-administered Heinrichs-Carpenter Quality of Life scale), clinically rated uncooperativeness (as assessed by PANSS G8), and discontinuation of treatment for all causes (all P. <. 0.05 for statistical interaction between insight and subject QoL). Patients with chronic schizophrenia who reported being "pleased" or "delighted" on LQOLI were found to have significantly lower neurocognitive reasoning performance and poorer insight (ITAQ total score). Our findings underscore the importance of reducing cognitive and insight impairments for both treatment compliance and improved functional outcomes.

Original languageEnglish (US)
Pages (from-to)127-132
Number of pages6
JournalSchizophrenia Research: Cognition
Volume2
Issue number3
DOIs
StatePublished - Sep 1 2015

Fingerprint

Schizophrenia
Quality of Life
Interviews
National Institute of Mental Health (U.S.)
Symptom Assessment
Therapeutics
Antipsychotic Agents
Clinical Trials
Surveys and Questionnaires

Keywords

  • Insight into illness
  • Neurocognition
  • Patient-rated quality of life
  • Schizophrenia
  • Subjective well-being

ASJC Scopus subject areas

  • Cognitive Neuroscience
  • Psychiatry and Mental health

Cite this

Insight and subjective measures of quality of life in chronic schizophrenia. / Siu, Cynthia O.; Harvey, Philip D; Agid, Ofer; Waye, Mary; Brambilla, Carla; Choi, Wing Kit; Remington, Gary.

In: Schizophrenia Research: Cognition, Vol. 2, No. 3, 01.09.2015, p. 127-132.

Research output: Contribution to journalArticle

Siu, Cynthia O. ; Harvey, Philip D ; Agid, Ofer ; Waye, Mary ; Brambilla, Carla ; Choi, Wing Kit ; Remington, Gary. / Insight and subjective measures of quality of life in chronic schizophrenia. In: Schizophrenia Research: Cognition. 2015 ; Vol. 2, No. 3. pp. 127-132.
@article{e2e0c633fd1444aeaa0bd096896fd247,
title = "Insight and subjective measures of quality of life in chronic schizophrenia",
abstract = "Lack of insight is a well-established phenomenon in schizophrenia, and has been associated with reduced rater-assessed functional performance but increased self-reported well-being in previous studies. The objective of this study was to examine factors that might influence insight (as assessed by the Insight and Treatment Attitudes Questionnaire [ITAQ] or PANSS item G12) and subjective quality-of-life (as assessed by Lehman QoL Interview [LQOLI]), using the large National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) dataset. Uncooperativeness was assessed by PANSS item G8 ({"}Uncooperativeness{"}). In the analysis, we found significant moderating effects for insight on the relationships of subjective life satisfaction assessment to symptom severity (as assessed by CGI-S score), objective everyday functioning (as assessed by rater-administered Heinrichs-Carpenter Quality of Life scale), clinically rated uncooperativeness (as assessed by PANSS G8), and discontinuation of treatment for all causes (all P. <. 0.05 for statistical interaction between insight and subject QoL). Patients with chronic schizophrenia who reported being {"}pleased{"} or {"}delighted{"} on LQOLI were found to have significantly lower neurocognitive reasoning performance and poorer insight (ITAQ total score). Our findings underscore the importance of reducing cognitive and insight impairments for both treatment compliance and improved functional outcomes.",
keywords = "Insight into illness, Neurocognition, Patient-rated quality of life, Schizophrenia, Subjective well-being",
author = "Siu, {Cynthia O.} and Harvey, {Philip D} and Ofer Agid and Mary Waye and Carla Brambilla and Choi, {Wing Kit} and Gary Remington",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.scog.2015.05.002",
language = "English (US)",
volume = "2",
pages = "127--132",
journal = "Schizophrenia Research: Cognition",
issn = "2215-0013",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Insight and subjective measures of quality of life in chronic schizophrenia

AU - Siu, Cynthia O.

AU - Harvey, Philip D

AU - Agid, Ofer

AU - Waye, Mary

AU - Brambilla, Carla

AU - Choi, Wing Kit

AU - Remington, Gary

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Lack of insight is a well-established phenomenon in schizophrenia, and has been associated with reduced rater-assessed functional performance but increased self-reported well-being in previous studies. The objective of this study was to examine factors that might influence insight (as assessed by the Insight and Treatment Attitudes Questionnaire [ITAQ] or PANSS item G12) and subjective quality-of-life (as assessed by Lehman QoL Interview [LQOLI]), using the large National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) dataset. Uncooperativeness was assessed by PANSS item G8 ("Uncooperativeness"). In the analysis, we found significant moderating effects for insight on the relationships of subjective life satisfaction assessment to symptom severity (as assessed by CGI-S score), objective everyday functioning (as assessed by rater-administered Heinrichs-Carpenter Quality of Life scale), clinically rated uncooperativeness (as assessed by PANSS G8), and discontinuation of treatment for all causes (all P. <. 0.05 for statistical interaction between insight and subject QoL). Patients with chronic schizophrenia who reported being "pleased" or "delighted" on LQOLI were found to have significantly lower neurocognitive reasoning performance and poorer insight (ITAQ total score). Our findings underscore the importance of reducing cognitive and insight impairments for both treatment compliance and improved functional outcomes.

AB - Lack of insight is a well-established phenomenon in schizophrenia, and has been associated with reduced rater-assessed functional performance but increased self-reported well-being in previous studies. The objective of this study was to examine factors that might influence insight (as assessed by the Insight and Treatment Attitudes Questionnaire [ITAQ] or PANSS item G12) and subjective quality-of-life (as assessed by Lehman QoL Interview [LQOLI]), using the large National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) dataset. Uncooperativeness was assessed by PANSS item G8 ("Uncooperativeness"). In the analysis, we found significant moderating effects for insight on the relationships of subjective life satisfaction assessment to symptom severity (as assessed by CGI-S score), objective everyday functioning (as assessed by rater-administered Heinrichs-Carpenter Quality of Life scale), clinically rated uncooperativeness (as assessed by PANSS G8), and discontinuation of treatment for all causes (all P. <. 0.05 for statistical interaction between insight and subject QoL). Patients with chronic schizophrenia who reported being "pleased" or "delighted" on LQOLI were found to have significantly lower neurocognitive reasoning performance and poorer insight (ITAQ total score). Our findings underscore the importance of reducing cognitive and insight impairments for both treatment compliance and improved functional outcomes.

KW - Insight into illness

KW - Neurocognition

KW - Patient-rated quality of life

KW - Schizophrenia

KW - Subjective well-being

UR - http://www.scopus.com/inward/record.url?scp=84942190869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942190869&partnerID=8YFLogxK

U2 - 10.1016/j.scog.2015.05.002

DO - 10.1016/j.scog.2015.05.002

M3 - Article

AN - SCOPUS:84942190869

VL - 2

SP - 127

EP - 132

JO - Schizophrenia Research: Cognition

JF - Schizophrenia Research: Cognition

SN - 2215-0013

IS - 3

ER -